guanabenz and methyldopa
guanabenz has been researched along with methyldopa in 22 studies
Research
Studies (22)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (59.09) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 3 (13.64) | 29.6817 |
2010's | 4 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Helfant, RH; Ramanathan, KB; Shah, RS; Vanov, SK; Walker, BR | 1 |
Chiummo, R | 1 |
Bhandare, PN; D'Souza, RS; Rataboli, PV | 1 |
MacLeod, SM; Manmontri, A | 1 |
Gehr, M; Goldberg, M | 1 |
Kaplan, NM | 1 |
Pandhi, P; Sharma, PL | 1 |
Giles, TD; Quiroz, AC; Sander, GE; Thomas, MG | 1 |
Gehr, M; Goldberg, M; MacCarthy, EP | 1 |
Drayer, JI; Weber, MA | 2 |
Houston, MC | 1 |
Finnerty, FA | 1 |
Rosendorff, C | 1 |
Deitch, MW; Hare, LE; Schneider, BE; Walker, BR | 1 |
Takishita, S; Yamazato, M | 1 |
Sica, DA | 1 |
Reviews
6 review(s) available for guanabenz and methyldopa
Article | Year |
---|---|
Centrally acting sympatholytic agents in the treatment of congestive heart failure. A review of the literature.
Topics: Bromocriptine; Clinical Trials as Topic; Clonidine; Guanabenz; Heart Failure; Humans; Methyldopa; Sympatholytics | 1990 |
Centrally acting antihypertensive agents: a brief overview.
Topics: Animals; Antihypertensive Agents; Central Nervous System; Clonidine; Guanabenz; Humans; Hypertension; Methyldopa; Reserpine; Sympathetic Nervous System | 1984 |
Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome.
Topics: Acute Disease; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bethanidine; Blood Pressure; Clonidine; Guanabenz; Heart Failure; Humans; Hypertension; Methyldopa; Myocardial Infarction; Pressoreceptors; Prospective Studies; Substance Withdrawal Syndrome; Syndrome; Time Factors | 1981 |
Central and peripheral blockade of the sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics | 1984 |
[Centrally-acting antihypertensive drugs].
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Guanabenz; Guanfacine; Humans; Hypertension; Imidazoline Receptors; Kidney; Methyldopa; Norepinephrine; Pressoreceptors; Receptors, Drug; Renal Circulation; Sodium; Sympathetic Nervous System; Sympatholytics; Vascular Resistance | 2004 |
Centrally acting antihypertensive agents: an update.
Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Blood Pressure; Clonidine; Contraindications; Guanabenz; Guanfacine; Humans; Hypertension; Imidazoles; Methyldopa; Oxazoles; Rilmenidine | 2007 |
Trials
4 trial(s) available for guanabenz and methyldopa
Article | Year |
---|---|
Guanabenz and methyldopa on hypertension and cardiac performance.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Guanabenz; Guanidines; Hemodynamics; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1977 |
Alpha-adrenergic mechanisms in the pathophysiology of left ventricular heart failure--an analysis of their role in systolic and diastolic dysfunction.
Topics: Adrenergic alpha-Antagonists; Autonomic Nervous System; Central Nervous System; Clinical Trials as Topic; Clonidine; Diastole; Guanabenz; Heart Failure; Heart Ventricles; Humans; Methyldopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Stroke Volume; Systole | 1986 |
Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Guanabenz; Guanidines; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1982 |
Comparative antihypertensive effects of guanabenz and methyldopa.
Topics: Blood Pressure; Body Weight; Double-Blind Method; Drug Evaluation; Female; Guanabenz; Guanidines; Humans; Hypertension; Male; Methyldopa; Posture; Random Allocation | 1981 |
Other Studies
12 other study(ies) available for guanabenz and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
Topics: Aged; Antihypertensive Agents; Drug Evaluation; Female; Guanabenz; Guanidines; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1975 |
Dual action of clonidine on ethanol-induced gastric lesions: is the imidazoline-preferring receptor involved?
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Dose-Response Relationship, Drug; Ethanol; Guanabenz; Imidazoline Receptors; Male; Methyldopa; Oxymetazoline; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Drug; Stomach; Yohimbine | 1991 |
Effects of alpha-2 agonists on renal function in hypertensive humans.
Topics: Adrenergic alpha-Agonists; Clonidine; Diuresis; Glomerular Filtration Rate; Guanabenz; Humans; Hypertension; Kidney; Methyldopa; Natriuresis | 1985 |
Alpha 2-adrenoceptor agonists in the treatment of hypertension.
Topics: Adrenergic alpha-Agonists; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Lipids; Methyldopa | 1985 |
Progress in the treatment of essential hypertension.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Methyldopa; Vasodilator Agents | 1985 |
Natriuretic and water diuretic effects of central alpha 2-adrenoceptor agonists.
Topics: Adrenergic alpha-Agonists; Blood Pressure; Blood Volume; Clonidine; Diuresis; Guanabenz; Homeostasis; Humans; Methyldopa; Natriuresis; Sodium; Water-Electrolyte Balance | 1984 |
Office management of hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Captopril; Clonidine; Diuretics; Guanabenz; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Prazosin; Reserpine; Sodium Chloride Symporter Inhibitors | 1984 |